A recent report by Slebe et al. demonstrated that the increased catalytic activity of LIPG is required for breast cancer cell growth and proliferation because it is responsible for hydrolyzing extracellular phospholipids, from HDL, which are then incorporated into intracellular lipids to provide the necessary lipid precursors for breast cancer cells [42]. This evidence concerns the gene LIPG and breast carcinoma.